T Man Pharmaceutical PCL
SET:TMAN
Income Statement
Earnings Waterfall
T Man Pharmaceutical PCL
Income Statement
T Man Pharmaceutical PCL
| Mar-2025 | Jun-2025 | ||
|---|---|---|---|
| Revenue | |||
| Revenue |
2 220
N/A
|
2 231
+1%
|
|
| Gross Profit | |||
| Cost of Revenue |
(1 141)
|
(1 126)
|
|
| Gross Profit |
1 079
N/A
|
1 105
+2%
|
|
| Operating Income | |||
| Operating Expenses |
(546)
|
0
|
|
| Selling, General & Administrative |
(563)
|
(577)
|
|
| Other Operating Expenses |
16
|
19
|
|
| Operating Income |
532
N/A
|
0
N/A
|
|
| Pre-Tax Income | |||
| Interest Income Expense |
(23)
|
(28)
|
|
| Total Other Income |
2
|
(1)
|
|
| Pre-Tax Income |
511
N/A
|
519
+1%
|
|
| Net Income | |||
| Tax Provision |
(78)
|
(78)
|
|
| Income from Continuing Operations |
433
|
0
|
|
| Income to Minority Interest |
(0)
|
0
|
|
| Net Income (Common) |
433
N/A
|
0
N/A
|
|
| EPS (Diluted) |
1.08
N/A
|
0
N/A
|
|